<table id="t8" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8 Treatment-Emergent NS3 Protease Domain Amino Acid Substitutions Detected Among Subjects treated with VICTRELIS in SPRINT-2, RESPOND-2 and P06086 Who Did Not Achieve a Sustained Virologic Response (SVR)</caption>
<col align="left" valign="middle" width="33%"></col>
<col align="left" valign="middle" width="33%"></col>
<col align="left" valign="middle" width="34%"></col>
<thead>
<tr>
<th stylecode="Lrule Rrule"></th>
<th align="center" stylecode="Rrule">Subjects Infected with HCV Genotype 1a</th>
<th align="center" stylecode="Rrule">Subjects Infected with HCV Genotype 1b</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">&gt;10% of subjects treated with VICTRELIS  who did not achieve SVR</td>
<td stylecode="Rrule">V36M, T54S, R155K</td>
<td stylecode="Rrule">T54A, T54S, V55A, A156S, V170A</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">&lt;1% to 10% of subjects treated with VICTRELIS who did not achieve SVR</td>
<td stylecode="Rrule">V36A, T54A, V55A, V55I, V107I, R155T, A156S, A156T, V158I, D168N, I170F, I170T, I170V</td>
<td stylecode="Rrule">V36A, V36M, T54C, T54G, V107I, R155C, R155K, A156T, A156V, V158I, I/V170T, M175L</td>
</tr>
</tbody>
</table>